Healthy Recovery After Trauma Study (HRT)
Stress Disorders, Post-Traumatic, Shame, Guilt
About this trial
This is an interventional treatment trial for Stress Disorders, Post-Traumatic focused on measuring post-traumatic stress disorder, mental contamination, cognitive processing therapy, self-compassion, shame, guilt, sexual trauma
Eligibility Criteria
Inclusion Criteria:
- individuals with a history of sexual trauma meeting past-month diagnostic criteria for PTSD (meeting diagnostic status on the DIAMOND and score greater than or equal to 36 on the PCL-5) and
- reporting current experiences of trauma-related mental contamination (greater than or equal to 10 on the PEMC).
- 18 years of age or older
- fluent in English
- Patients on psychotropic medications will be included if they have been maintained on a stable dose for at least 4 weeks prior to beginning the study and are willing to maintain a stable dosage throughout the study period; this procedure allows for a broader range of participants and avoids having outcomes assessment confounded by the initiation of medication during treatment.
- Finally, patients must be willing to refrain from additional trauma-related treatment for the duration of the study.
Exclusion Criteria:
- We will exclude individuals diagnosed with psychological conditions that may be better addressed by alternative treatments; these conditions include
- psychotic disorders
- dissociative identity disorder
- unmanaged (i.e., unmedicated or currently experiencing a manic/hypomanic episode) bipolar disorder
- bulimia nervosa
- anorexia nervosa
- imminent risk of suicide (i.e., intent/plan)
- severe substance use disorders.
Sites / Locations
- University of Kentucky Clinic for Emotional Health (CEH)Recruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
2 week baseline, CPT + SC
2 week baseline, SC + CPT
4 week baseline, CPT + SC
4 week baseline, SC + CPT
Participants in this arm are randomized to a 2-week baseline period with repeated weekly assessment after the initial intake. Following the 2-week baseline, participants are randomly assigned to receive 12 weekly sessions of Cognitive Processing Therapy (CPT), followed by a 3-week return to baseline period, followed by 6 weekly sessions of Self-Compassion Therapy (SC).
Participants in this arm are randomized to a 2-week baseline period with repeated weekly assessment after the initial intake. Following the 2-week baseline, participants are randomly assigned to receive 6 weekly sessions of Self-Compassion Therapy (SC), followed by a 3-week return to baseline period, followed by 12 weekly sessions of Cognitive Processing Therapy (CPT).
Participants in this arm are randomized to a 4-week baseline period with repeated weekly assessment after the initial intake. Following the 4-week baseline, participants are randomly assigned to receive 12 weekly sessions of Cognitive Processing Therapy (CPT), followed by a 3-week return to baseline period, followed by 6 weekly sessions of Self-Compassion Therapy (SC).
Participants in this arm are randomized to a 4-week baseline period with repeated weekly assessment after the initial intake. Following the 4-week baseline, participants are randomly assigned to receive 6 weekly sessions of Self-Compassion Therapy (SC), followed by a 3-week return to baseline period, followed by 12 weekly sessions of Cognitive Processing Therapy (CPT).